These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 9724858

  • 41. Multibacillary leprosy: follow up observations on 19 patients treated with 12 monthly doses of rifampicin, ofloxacin and minocycline therapy in Agra.
    Kumar A, Girdhar BK.
    Indian J Dermatol Venereol Leprol; 2014; 80(2):156-9. PubMed ID: 24685858
    [No Abstract] [Full Text] [Related]

  • 42. Distinct histopathological patterns in single lesion leprosy patients treated with single dose therapy (ROM) in the Brazilian Multicentric Study.
    Costa MB, Cavalcanti Neto PF, Martelli CM, Stefani MM, Maceira JP, Gomes MK, Schettini AP, Rebello PF, Pignataro PE, Ueda ES, Narahashi K, Scollard DM.
    Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):177-86. PubMed ID: 11875761
    [Abstract] [Full Text] [Related]

  • 43. A 6 week quadruple drug regimen for the treatment of multibacillary leprosy.
    Pattyn S, Grillone S.
    Lepr Rev; 2000 Mar; 71(1):43-6. PubMed ID: 10820986
    [No Abstract] [Full Text] [Related]

  • 44. World Health Organization (WHO) antibiotic regimen against other regimens for the treatment of leprosy: a systematic review and meta-analysis.
    Lazo-Porras M, Prutsky GJ, Barrionuevo P, Tapia JC, Ugarte-Gil C, Ponce OJ, Acuña-Villaorduña A, Domecq JP, De la Cruz-Luque C, Prokop LJ, Málaga G.
    BMC Infect Dis; 2020 Jan 20; 20(1):62. PubMed ID: 31959113
    [Abstract] [Full Text] [Related]

  • 45. Ofloxacin containing combined drug regimens in the treatment of multibacillary leprosy.
    Sampoonachot P, Bundit C, Kuhacharoen N, Peerapakorn S, Kampirapap K, Poomlek A, Bampenyu S, Tiasiri S, Rungruang S, Surasondhi S, Supanwanit S, Wiriyawipart S.
    Southeast Asian J Trop Med Public Health; 1997 Dec 20; 28(4):803-10. PubMed ID: 9656405
    [Abstract] [Full Text] [Related]

  • 46. Report of workshop on chemotherapy.
    Grosset JH, Franzblau S.
    Int J Lepr Other Mycobact Dis; 1998 Dec 20; 66(4):595-6. PubMed ID: 10347587
    [No Abstract] [Full Text] [Related]

  • 47. Multidrug therapy regimen for leprosy.
    Firooz A.
    J Am Acad Dermatol; 2006 Dec 20; 55(6):1115; author reply 1115. PubMed ID: 17110233
    [No Abstract] [Full Text] [Related]

  • 48. A study on trend of relapse in leprosy and factors influencing relapse.
    Ali MK, Thorat DM, Subramanian M, Parthasarathy G, Selvaraj U, Prabhakar V.
    Indian J Lepr; 2005 Dec 20; 77(2):105-15. PubMed ID: 16044808
    [Abstract] [Full Text] [Related]

  • 49. Analysis of bacteriological Index between fixed multidrug therapy and new WHO recommended alternative regimen with ofloxacin, minocycline and clofazimine of rifampicin resistant cases from the hospitals of The Leprosy Mission, India.
    Lavania M, Darlong J, Singh I, Ahuja M, Turankar RP, Pathak VK, Kumar A, Nathan R, Sengupta U.
    J Glob Antimicrob Resist; 2020 Dec 20; 23():275-277. PubMed ID: 33068781
    [No Abstract] [Full Text] [Related]

  • 50. Evaluation of anti-bacterial activity of Rifapentine, Clarithromycin, Minocycline, Moxifloxacin, Ofloxacin and their combinations in Murine Model of Rifampicin Resistant Leprosy.
    Joseph P, Ponnaiya J, Das M, Chaitanya VS, Arumugam S, Ebenezer M.
    Indian J Lepr; 2016 Dec 20; 88(3):147-58. PubMed ID: 30207440
    [Abstract] [Full Text] [Related]

  • 51. Leprosy situation in endemic states of India and prospects of elimination of the disease.
    Subramanian M, Showkath Ali MK, Thorat DM, Muthukumar M, Sathiskumar E, Ramadoss C, Ali Khan M.
    Indian J Lepr; 2003 Dec 20; 75(4):335-45. PubMed ID: 15242272
    [Abstract] [Full Text] [Related]

  • 52. [Recurrent lepromatous leprosy in conventional triple therapy: value of the rifampicin-ofloxacin combination].
    Marlier S, Carsuzaa F, De Jaureguiberry JP, Galzin M, Carloz E, Carli P, Chagnon A.
    Med Trop (Mars); 1995 Dec 20; 55(2):182. PubMed ID: 7565004
    [No Abstract] [Full Text] [Related]

  • 53. Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice.
    Ji B, Perani EG, Petinom C, Grosset JH.
    Antimicrob Agents Chemother; 1996 Feb 20; 40(2):393-9. PubMed ID: 8834886
    [Abstract] [Full Text] [Related]

  • 54. Lesional characteristics and histopathology in paucibacillary leprosy patients with 2 or 3 skin lesions: comparison between ROM and PB-MDT regimens.
    Emmanuel M, Gupte MD.
    Indian J Lepr; 2005 Feb 20; 77(1):19-25. PubMed ID: 16173416
    [Abstract] [Full Text] [Related]

  • 55. Multidrug therapy in leprosy.
    Manglani PR, Arif MA.
    J Indian Med Assoc; 2006 Dec 20; 104(12):686-8. PubMed ID: 17474286
    [Abstract] [Full Text] [Related]

  • 56. Granuloma annulare treated with rifampin, ofloxacin, and minocycline combination therapy.
    Marcus DV, Mahmoud BH, Hamzavi IH.
    Arch Dermatol; 2009 Jul 20; 145(7):787-9. PubMed ID: 19620560
    [Abstract] [Full Text] [Related]

  • 57. A rare variant of erythema nodosum leprosum: a case report.
    Dave S, Thappa DM, Nori AV, Jayanthi S.
    Dermatol Online J; 2003 Dec 20; 9(5):11. PubMed ID: 14996384
    [Abstract] [Full Text] [Related]

  • 58. [Correlation between dose/plasma concentration and assessment of hepatic and renal changes in Wistar rats treated with the ROM scheme].
    Malfará WR, Uyemura SA, Queiroz RH.
    Rev Soc Bras Med Trop; 2005 Dec 20; 38(2):167-72. PubMed ID: 15821793
    [Abstract] [Full Text] [Related]

  • 59. Bactericidal activity of a single-dose combination of ofloxacin plus minocycline, with or without rifampin, against Mycobacterium leprae in mice and in lepromatous patients.
    Ji B, Sow S, Perani E, Lienhardt C, Diderot V, Grosset J.
    Antimicrob Agents Chemother; 1998 May 20; 42(5):1115-20. PubMed ID: 9593137
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.